Kiora Pharmaceuticals, Inc. (KPRX)

Kiora Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	5.51	3.79	2.45	5.96	7.85	1.19
Short-Term Investments	13.87	23	-	-	-	-
Cash & Short-Term Investments	19.38	26.79	2.45	5.96	7.85	1.19
Cash Growth	-33.27%	991.47%	-58.85%	-24.06%	562.47%	-68.61%
Accounts Receivable	1.21	0.6	-	-	-	-
Other Receivables	1.45	0.27	2.05	1.37	0.53	0.09
Receivables	2.67	0.87	2.05	1.37	0.53	0.09
Prepaid Expenses	0.21	2.04	0.23	0.34	0.61	0.45
Other Current Assets	0.44	-	-	-	-	-
Total Current Assets	22.69	29.71	4.74	7.68	8.99	1.73
Property, Plant & Equipment	0.42	0.06	0.11	0.17	0.28	0.11
Goodwill	-	-	-	-	-	3.63
Other Intangible Assets	-	-	0.12	0.14	0.17	0.19
Long-Term Deferred Charges	6.69	6.69	8.7	10.6	10.6	9.54
Other Long-Term Assets	0.06	0.03	0.05	0.08	0.09	0.1
Total Assets	29.86	36.48	13.71	18.68	20.13	15.3
Accounts Payable	0.24	0.42	0.21	1.01	0.16	0.43
Accrued Expenses	2.15	2.26	1.38	1.84	1.33	1.29
Current Portion of Long-Term Debt	-	-	-	-	-	0.21
Current Portion of Leases	0.16	0.02	0.05	0.11	0.12	0.05
Current Income Taxes Payable	-	2.33	-	-	-	-
Other Current Liabilities	0.03	0.98	-	0.32	-	-
Total Current Liabilities	2.58	6.01	1.63	3.27	1.61	1.98
Long-Term Debt	-	-	-	-	-	0.28
Long-Term Leases	0.25	0.03	0.06	-	0.09	0.04
Long-Term Deferred Tax Liabilities	0.49	0.49	0.78	0.69	0.8	0.73
Other Long-Term Liabilities	2.88	4.19	5.13	3.31	3.05	2.55
Total Liabilities	7.45	10.72	7.6	7.27	5.55	5.57
Common Stock	0.27	0.27	0.08	0.02	0	0.06
Additional Paid-In Capital	170.08	169.16	153.19	146.04	135.54	116.78
Retained Earnings	-147.7	-143.38	-146.98	-134.46	-120.88	-107.11
Comprehensive Income & Other	-0.24	-0.28	-0.18	-0.18	-0.09	-0
Total Common Equity	22.41	25.76	6.11	11.41	14.58	9.73
Shareholders' Equity	22.41	25.76	6.11	11.41	14.58	9.73
Total Liabilities & Equity	29.86	36.48	13.71	18.68	20.13	15.3
Total Debt	0.4	0.06	0.11	0.11	0.21	0.57
Net Cash (Debt)	18.97	26.73	2.35	5.86	7.65	0.61
Net Cash Growth	-34.50%	1038.72%	-59.93%	-23.37%	1150.70%	-83.45%
Net Cash Per Share	4.54	6.48	4.36	72.00	285.39	47.93
Filing Date Shares Outstanding	3.67	3	2.92	0.21	0.04	0.02
Total Common Shares Outstanding	3.43	3	0.86	0.2	0.04	0.02
Working Capital	20.11	23.7	3.1	4.41	7.38	-0.26
Book Value Per Share	6.53	8.58	7.14	57.15	414.44	630.41
Tangible Book Value	22.41	25.76	5.99	11.26	14.41	5.9
Tangible Book Value Per Share	6.53	8.58	7.00	56.43	409.64	382.58
Machinery	-	0.01	0.01	0.15	0.16	0.1
Leasehold Improvements	-	-	-	0.02	0.02	0.02

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q